If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email firstname.lastname@example.org.
Please tell us what format you need. It will help us if you say what assistive technology you use.
The Health Protection Agency (now Public Health England) expert working group recommended the use of intravenous products only for the treatment of clinically suspected tetanus.
For tetanus prone wounds requiring intramuscular (IM) tetanus immunoglobulin (TIG), human normal immunoglobulin for subcutaneous use (Subgam) may be given intramuscularly as an alternative if stocks of IM TIG are not available.